Medicare Enrolled
Dr. Vasco Marques, MD
Interventional Cardiology · Tampa, FL
Practice pattern: Cardiac & Remote
— Practice combining cardiac and remote services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Marques from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marques?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Marques
Dr. Vasco Marques is an interventional cardiology specialist in Tampa, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Marques performed 3,042 Medicare services across 1,930 unique beneficiaries.
Between the years covered by Open Payments, Dr. Marques received a total of $62,083 from 63 pharmaceutical and/or device companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marques is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 35% volume in FL
$62,083 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,042
Medicare services
Top 35% in FL for interventional cardiology
1,930
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~160 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
529 | $91 | $215 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
523 | $63 | $146 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
404 | $48 | $190 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
252 | $90 | $236 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
170 | $146 | $449 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
148 | $27 | $72 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
136 | $49 | $152 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
126 | $333 | $954 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
107 | $16 | $51 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
90 | $20 | $54 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
65 | $21 | $69 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
58 | $19 | $55 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
53 | $134 | $387 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
43 | $27 | $138 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
42 | $13 | $44 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
40 | $22 | $78 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
37 | $9 | $32 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
37 | $20 | $59 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $81 | $218 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
29 | $149 | $398 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
25 | $9 | $32 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
25 | $19 | $54 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
25 | $179 | $508 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
19 | $93 | $236 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
16 | $1,267 | $4,149 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
13 | $140 | $376 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.4% high complexity
34.8% medium
50.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$62,083
Total received (2018-2024)
Avg $8,869/year across 7 years
Top 8% in FL for interventional cardiology
63
Companies
548
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50,069 (80.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,252 (18.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$762 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$21
2023
$18,699
2022
$1,596
2021
$810
2020
$3,279
2019
$16,874
2018
$20,803
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$32,539
Medtronic, Inc.
$17,572
BIOTRONIK INC.
$1,469
Penumbra, Inc.
$1,213
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,103
Novartis Pharmaceuticals Corporation
$607
Abbott Laboratories
$593
AstraZeneca Pharmaceuticals LP
$502
E.R. Squibb & Sons, L.L.C.
$450
SANOFI-AVENTIS U.S. LLC
$446
Lundbeck LLC
$414
PFIZER INC.
$378
Amgen Inc.
$338
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$335
ACIST MEDICAL SYSTEMS, INC.
$318
Vital Connect, Inc
$280
PORTOLA PHARMACEUTICALS, INC.
$273
Bayer HealthCare Pharmaceuticals Inc.
$253
Regeneron Healthcare Solutions, Inc.
$242
Janssen Pharmaceuticals, Inc
$225
Cook Medical LLC
$221
Actelion Pharmaceuticals US, Inc.
$217
Amarin Pharma Inc.
$209
Boston Scientific Corporation
$187
Merck Sharp & Dohme LLC
$152
ABIOMED
$150
EKOS Corporation
$110
Chiesi USA, Inc.
$107
BARD PERIPHERAL VASCULAR, INC.
$100
Esperion Therapeutics, Inc.
$80
Novo Nordisk Inc
$73
CVRx, Inc.
$65
Gilead Sciences, Inc.
$61
PORTOLA PHARMACEUTICALS, LLC
$56
Bayer Healthcare Pharmaceuticals Inc.
$54
Kestra Medical Technology Services, Inc.
$50
Astellas Pharma US Inc
$48
La Jolla Pharmaceutical Company
$40
Kowa Pharmaceuticals America, Inc.
$40
Kiniksa Pharmaceuticals, Ltd.
$37
Cardiovascular Systems Inc.
$35
BOSTON SCIENTIFIC CORPORATION
$34
Impulse Dynamics (USA) Inc.
$34
Quidel Corporation
$34
Edwards Lifesciences Corporation
$33
ATRICURE, INC.
$26
Inari Medical, Inc.
$23
ARGON MEDICAL DEVICES, INC.
$22
Philips Electronics North America Corporation
$20
AtriCure, Inc.
$20
Baxter Healthcare
$19
Cook Incorporated
$17
Arbor Pharmaceuticals, Inc.
$17
Tactile Systems Technology Inc
$16
Bardy Diagnostics, Inc.
$15
AngioDynamics, Inc.
$15
C. R. BARD, INC. & SUBSIDIARIES
$14
Amryt Pharma Holdings Ltd
$14
HeartFlow, Inc.
$14
InfoBionic, Inc
$14
LivaNova USA, Inc.
$14
ARALEZ PHARMACEUTICALS US INC.
$13
CHIESI USA, INC.
$11
Top 3 companies account for 83.1% of total payments
Associated products mentioned in payments ›
(5044) MCOT · ANDEXXA · ANGIOJET · ATRICLIP LAA EXCLUSION SYSTEM · Acticor 7 VR-T DX · Adempas · Arcalyst · Assure WCD · Azure · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CLEVIPREX · CLOSUREFAST · CONFIRM RX · COOK MEDICAL STENTS · COOK MEDICAL ZILVER PTX · CVI CONSUMABLES · CVI SYSTEMS · CardioMEMS HF System · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · Cook Medical Angioplasty · Cook Medical Self-Expanding Stent · Cook Medical Zilver · Cook Medical Zilver PTX · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · EKOSONIC · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbyclor · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FLEXITOUCH · FlowTriever · Fortify Assura · GENERAL ANGIOPLASTY · GENERAL VASCULAR INTERVENTION · GENERAL - THERAPIES · GIAPREZA · Hillrom - Cardiac Ambulatory Monitor · Impella · Indigo · Indigo System · JARDIANCE · Juxtapid · KENGREAL · KENGREAL 50MG/10ML L · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LOKELMA · LifeVest · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · MoMe Kardia · NEXLETOL · NORTHERA · OPSUMIT · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · Peripheral Orbital Atherectomy System · ProtekDuo Kit · RESONATE · RXI CONSUMABLES · RXI SYSTEMS · RYBELSUS · Repatha · Resolute · Reveal LINQ · Rybelsus · THROMBECTOMY · Triage · VENACURE 1470 PRO · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · VenaSeal · Verquvo · WATCHMAN · WATCHMAN Access System · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for interventional cardiology in FL.
Equivalent to $2,041 per 100 Medicare services performed
Geographic Context
Interventional cardiologists within 10 mi
48
Per 100K population
3.2
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Marques is a cardiac & remote specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Marques experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Marques performed 529 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marques receive payments from pharmaceutical companies?
Yes. Dr. Marques received a total of $62,083 from 63 companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marques's costs compare to other interventional cardiologists in Tampa?
Dr. Marques's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marques) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Tampa
Browse interventional cardiologists in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in FL
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in FL
Which FL interventional cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology